Spunout from and anchored in IP licensed from Johns Hopkins, Vixiar Medical, Inc. is developing non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases, particularly those with significant clinical and economic burden. The Companyâs first product, Indicorâ¢, is a handheld point of care device and digital platform for monitoring worsening heart failure. The portable, hand-held device assesses cardiac filling pressures for monitoring congestive heart failure (HF) and canbe used at the point of care in hospitals, physicianâs offices, nursing facilities and other clinical settings. The device is an alternative to more labor intensive, more expensive, invasive or less accurate approaches and is designed to prevent hospital readmissions and improve clinical management o
